J&J reports promising Ebola vaccine data
Sept. 14, 2021 Johnson & Johnson says its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal. The two-dose…
Political Economist A liberal news magazine reporting Nigeria & World News, Sports, Business & Economy…
 
  
Sept. 14, 2021 Johnson & Johnson says its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal. The two-dose…